Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Hemogenyx Pharmaceuticals (HEMO) Share Price

Price 602.00p on 08-01-2026 at 19:40:05
Change 14.00p 2.3%
Buy 648.00p
Sell 600.00p
Last Trade: Buy 1.00 at 647.7984p
Day's Volume: 39,936
Last Close: 624.00p
Open: 648.00p
ISIN: GB00BQVXM815
Day's Range 602.00p - 648.00p
52wk Range: 124.50p - 1,790.00p
Market Capitalisation: £36.37m
VWAP: 625.75912p
Shares in Issue: 6.04m

Hemogenyx Pharmaceuticals (HEMO) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 1 647.7984p Ordinary
16:00:39 - 08-Jan-26
Buy* 141 627.84p Ordinary
15:49:10 - 08-Jan-26
Buy* 17 628.80p Ordinary
15:40:35 - 08-Jan-26
Sell* 30 612.96p Ordinary
15:18:07 - 08-Jan-26
Buy* 5 628.80p Ordinary
14:16:08 - 08-Jan-26
Buy* 170 628.80p Ordinary
14:14:42 - 08-Jan-26
Buy* 1 628.80p Ordinary
14:06:22 - 08-Jan-26
Buy* 31 648.00p SI Trade
13:46:05 - 08-Jan-26
Sell* 1,828 602.00p Automatic Execution
13:36:06 - 08-Jan-26
Unknown* 3,000 601.00p Negotiated Trade
13:36:00 - 08-Jan-26
See more Hemogenyx Pharmaceuticals trades

Hemogenyx Pharmaceuticals (HEMO) Share Price History

Time period:
to
Date Open High Low Close Volume
8th Jan 2026 (Thu) 648.00 648.00 602.00 624.00 39,936
7th Jan 2026 (Wed) 602.00 660.00 592.00 610.00 42,799
6th Jan 2026 (Tue) 578.00 578.00 546.00 578.00 19,906
5th Jan 2026 (Mon) 574.00 606.00 548.00 548.00 12,654
2nd Jan 2026 (Fri) 552.00 610.00 552.00 568.00 23,497
1st Jan 2026 (Thu) 572.00 572.00 572.00 572.00 0
31st Dec 2025 (Wed) 592.00 592.00 550.00 572.00 3,116
30th Dec 2025 (Tue) 556.00 574.00 550.00 570.00 15,762
29th Dec 2025 (Mon) 582.00 582.00 564.00 568.00 21,020
26th Dec 2025 (Fri) 596.00 596.00 596.00 596.00 0
25th Dec 2025 (Thu) 596.00 596.00 596.00 596.00 0
24th Dec 2025 (Wed) 596.00 596.00 596.00 596.00 985
23rd Dec 2025 (Tue) 628.00 628.00 582.00 600.00 16,664
22nd Dec 2025 (Mon) 616.00 634.00 550.00 634.00 45,707
19th Dec 2025 (Fri) 608.00 608.00 598.00 598.00 15,285
18th Dec 2025 (Thu) 602.00 670.00 602.00 643.00 23,651
17th Dec 2025 (Wed) 660.00 664.00 640.00 664.00 23,865
16th Dec 2025 (Tue) 612.00 656.00 602.00 626.00 35,075
15th Dec 2025 (Mon) 600.00 668.00 584.00 635.00 70,722
12th Dec 2025 (Fri) 616.00 616.00 556.00 574.00 39,345
11th Dec 2025 (Thu) 620.00 620.00 576.00 576.00 17,691
10th Dec 2025 (Wed) 548.00 628.00 548.00 571.00 32,979
9th Dec 2025 (Tue) 600.00 738.00 546.00 559.00 130,434
See more Hemogenyx Pharmaceuticals price history

Hemogenyx Pharmaceuticals (HEMO) Regulatory News

Date Source Headline
22nd Dec 2025 8:00 am RNS Update on Admission of Shares
18th Dec 2025 7:00 am RNS Issue of Equity
8th Dec 2025 12:48 pm RNS Holding(s) in Company
28th Nov 2025 7:00 am RNS Total Voting Rights
19th Nov 2025 11:47 am RNS Publication of Prospectus
29th Oct 2025 7:00 am RNS Clinical Trial Update and Grant of Share Awards
6th Oct 2025 7:00 am RNS Clearance to Initiate Pediatric Enrolment
30th Sep 2025 7:00 am RNS Half-year Report
30th Sep 2025 7:00 am RNS Total Voting Rights
23rd Sep 2025 7:00 am RNS Hemogenyx Signs Letter of Intent
See more Hemogenyx Pharmaceuticals regulatory news

Hemogenyx Pharmaceuticals (HEMO) Share News

Hemogenyx secures clearance for pediatric enrolment in leukemia trial

6th Oct 2025 14:22

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Monday said it has received clearance to begin pediatric enrolment in its phase 1 trial of a leukemia treatment. Read More

EARNINGS: Suspension damages Enwell Energy; forex hurts Hemogenyx

30th Sep 2025 13:11

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

Hemogenyx says exploring commercialisation of treatment for leukaemia

23rd Sep 2025 15:51

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Tuesday said it is has signed a letter of intent with Cellin Technologies OU, a Tallinn-based cell therapy company. Read More

Hemogenyx shares jump as third patient treated for leukaemia form

17th Sep 2025 11:54

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Wednesday said the third patient has been successfully treated in an ongoing phase 1 clinical trial for a form of leukaemia. Read More

Hemogenyx inks manufacturing partnership deal with Made Scientific

8th Sep 2025 16:27

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Monday said it has agreed a manufacturing partnership with US-based cell therapy contract development and manufacturing organisation Made Scientific. Read More

See more Hemogenyx Pharmaceuticals news
FTSE 100 Latest
Value10,044.69
Change-3.52

Login to your account

Forgot Password?

Not Registered